Research Library

Browse, search, and filter the complete database of verified scientific literature

Topics:
11 results for “n,n-dimethyltryptamine”
Year:–
Showing 11 of 155 articles

Filters

Category
Topics
Topics:
Study Type
Year Range
Year:–
Sort By
Clinical Trials
NewDOI Resolved

Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind

Melani A, Papini G, Bonaso M et al.
Biomedicines, 2026
Open Access
Pharmacokinetic study
Depression & Mood
NewDOI Resolved

Predicting drug-drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling

Ribeiro GSG, Paranhos BAPB, Dörr F et al.
Frontiers in molecular biosciences, 2026
Open Access
Pharmacokinetic study
Pharmacology
NewPubMed Verified

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics

Chaves C, Dos Santos RG, Dursun SM et al.
Frontiers in Psychiatry, 2024
5 citationsOpen Access
Review
Pharmacology
NewPubMed Verified

Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors

Egger K, Aicher HD, Cumming P et al.
Cellular and Molecular Life Sciences, 2024
10 citationsOpen Access
Comprehensive review
Reviews
NewPubMed Verified

Psychedelic therapy: a primer for primary care clinicians - N,N-dimethyltryptamine and ayahuasca

Shinozuka K, Tabaac BJ, Arenas A et al.
American Journal of Therapeutics, 2024
10 citations
Clinical primer / review
Pharmacology
NewPubMed Verified

Development of a physiologically based pharmacokinetic model of N,N-dimethyltryptamine, harmine, and their interactions from ayahuasca in rats and humans

Wittayakarn N, Tan YM, Choomalaiwong P et al.
Toxicological Sciences, 2025
Pharmacokinetic modeling